Literature DB >> 21114732

Surviving multi-trauma in the past.

Brian Cornish1, Lucian Bogdan Solomon, Keryn Walshe.   

Abstract

BACKGROUND: Surviving multi-trauma is strongly associated with emergent resuscitation and treatment in modern medical facilities. Multi-trauma survival before the advent of modern medicine is likely to have been extremely uncommon, particularly in primitive societies. The aim of this study was to investigate the case of an ancient Australian Aboriginal who appeared to have survived multi-trauma.
METHODS: We investigated the skeletal remains of an adult Australian Aboriginal with healed fractures of the right femur and humerus. The time of death was assessed by carbon dating. The sex and approximate age of the subject were assessed from the skeleton's morphometry. The fractured bones were assessed by visual inspection, plain radiographs and computer tomography (CT) scanning.
RESULTS: The remains were of a male aged approximately 50 years at the time of his death, approximately 1000 years ago, preceding European settlement. Analysis of the malunions indicated that all fractures occurred in one traumatic event, normally a life-threatening injury combination, and that the subject survived for years after this incident, despite no or failed active treatment of his fractures.
CONCLUSIONS: The survival of a man living in a primitive society after multi-trauma reflects an impressive depth of nursing and social support in a community of hunter gatherers.
© 2010 The Authors. ANZ Journal of Surgery © 2010 Royal Australasian College of Surgeons.

Entities:  

Mesh:

Year:  2010        PMID: 21114732     DOI: 10.1111/j.1445-2197.2010.05527.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  1 in total

1.  Osteological evidence of remote penetrating soft tissue trauma in skeletal remains.

Authors:  Lucian B Solomon; Brian Cornish; Keryn Walshe; Roger W Byard
Journal:  Forensic Sci Med Pathol       Date:  2015-01-23       Impact factor: 2.007

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.